Scinovex
article Open AccessTop 1% cited

Retroviral DNA Integration: ASLV, HIV, and MLV Show Distinct Target Site Preferences

PLoS Biology · 2004 · Vol. 2(8) · pp. e234–e234
Rick MitchellBrett BeitzelA. R. W. SchröderPaul ShinnHuaming ChenCharles C. BerryJoseph R. EckerFrederic D. Bushman

Abstract

The completion of the human genome sequence has made possible genome-wide studies of retroviral DNA integration. Here we report an analysis of 3,127 integration site sequences from human cells. We compared retroviral vectors derived from human immunodeficiency virus (HIV), avian sarcoma-leukosis virus (ASLV), and murine leukemia virus (MLV). Effects of gene activity on integration targeting were assessed by transcriptional profiling of infected cells. Integration by HIV vectors, analyzed in two primary cell types and several cell lines, strongly favored active genes. An analysis of the effects of tissue-specific transcription showed that it resulted in tissue-specific integration targeting by HIV, though the effect was quantitatively modest. Chromosomal regions rich in expressed genes were favored for HIV integration, but these regions were found to be interleaved with unfavorable regions at CpG islands. MLV vectors showed a strong bias in favor of integration near transcription start sites, as reported previously. ASLV vectors showed only a weak preference for active genes and no preference for transcription start regions. Thus, each of the three retroviruses studied showed unique integration site preferences, suggesting that virus-specific binding of integration complexes to chromatin features likely guides site selection.

CRISPR and Genetic EngineeringChromosomal and Genetic VariationsHIV Research and TreatmentBiologyGenomeGeneGeneticsMurine leukemia virusVirologyComputational biology

MeSH terms

Avian Sarcoma VirusesBinding SitesCell LineChromatinChromosomes, HumanDNA, ViralHeLa CellsHIVHumansLeukocytes, MononuclearModels, GeneticMolecular Sequence DataLeukemia Virus, MurineOligonucleotidesRetroviridae

Funding

  • James B. Pendleton Charitable Trust
  • Deutsche Forschungsgemeinschaft
  • National Institutes of Health
Citations
972
FWCI
24.50
field-weighted impact
References
42
Percentile
100%
vs. same field & year
Citations per year
Cited by
Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1
Journal of Clinical Investigation · 2008 · 1,810 citations
References
The Sequence of the Human Genome
Science · 2001 · 13,619 citations
The Sequence of the Human Genome
Clinical Chemistry · 2015 · 1,654 citations
Initial sequencing and analysis of the human genome
Nature · 2001 · 24,452 citations
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.